Major Customer Retreat Triggers Stock Decline and Legal Scrutiny
EPAM Systems, Inc. ($EPAM) is facing a securities fraud investigation from the Pomerantz Law Firm following a significant business headwind disclosed on February 19, 2026. The company announced that its largest NEORIS customer is ramping down business, a revelation that immediately spooked investors and sent shares tumbling. The disclosure prompted a 6.61% stock price decline of $9.20 per share over two consecutive trading sessions, erasing roughly $1.5-2 billion in market capitalization depending on share count.
The investigation centers on whether EPAM Systems failed to adequately warn investors about the deteriorating customer relationship before the formal announcement. Pomerantz Law Firm, a prominent securities litigation boutique, is investigating potential claims that the company's statements or omissions regarding customer concentration risk may have constituted securities fraud. The firm is simultaneously investigating similar claims against Chemours Company ($CC) and Alight, Inc. ($ALIT), suggesting potential sector-wide disclosure issues.
The Business Impact and Customer Concentration Risk
The loss of business from NEORIS, EPAM Systems' largest customer, represents a material negative event for the company. Customer concentration has long been a structural risk for EPAM, which derives significant revenue from a limited number of enterprise clients. The ramping down of business from the top customer raises immediate questions about:
- Revenue visibility: Impact on forward guidance and future quarters' financial performance
- Profitability: Whether margins will compress as fixed costs are absorbed over lower revenue
- Market share loss: Whether competitors are winning business from this customer relationship
- Disclosure obligations: Whether EPAM had early warning signals that should have been disclosed earlier
The timing of the disclosure matters considerably for securities litigation. If evidence emerges that EPAM Systems management had knowledge of deteriorating conditions weeks or months before the February 19 announcement, the company could face significant liability exposure. Securities law requires timely disclosure of material information that would affect an investor's decision-making.
Market Context: Software Services Under Pressure
The investigation arrives during a challenging period for IT services and consulting companies. The sector has faced headwinds from:
- Macroeconomic uncertainty: CIOs and enterprise buyers reducing discretionary IT spending
- AI disruption concerns: Questions about whether generative AI reduces demand for traditional consulting services
- Client consolidation: Large enterprises consolidating vendor relationships to reduce costs
- Margin compression: Competitive pricing pressure as IT service providers compete for dwindling project pipelines
EPAM Systems is part of a broader ecosystem that includes Accenture ($ACN), IBM ($IBM), Cognizant ($CTSH), and WillScot Mobile Mini's IT peers. Many have reported customer concentration risks, though EPAM's reliance on NEORIS appears particularly acute given this represents the single largest customer relationship.
The concurrent investigations into Chemours and Alight suggest either a coincidental legal blitz from Pomerantz or broader concerns about disclosure practices across multiple industrial sectors. Chemours, a specialty chemical manufacturer spun from DuPont, and Alight, a benefits management and human capital software provider, operate in different industries, which makes their simultaneous investigation less obviously connected than sector-specific headwinds.
Investor Implications and Legal Exposure
For EPAM Systems shareholders, the implications are multifaceted:
Immediate Stock Price Risk: Beyond the initial 6.61% decline, securities litigation investigations typically apply downward pressure on stocks until resolution. Investors often sell on uncertainty, anticipating:
- Potential settlements or judgments
- Management distraction and operational uncertainty
- Revision of financial guidance
- Reputational damage affecting new customer acquisition
Litigation Exposure: If Pomerantz successfully establishes a securities class action, EPAM Systems faces potential damages, settlements, and costs associated with defending the litigation. The company's directors and officers liability insurance typically covers such scenarios, but deductibles and coverage limits may apply.
Customer and Talent Retention: The disclosure may accelerate customer attrition if other clients view EPAM Systems as facing operational or financial distress. Similarly, top talent may seek opportunities at competitors perceived as more stable.
Strategic Flexibility: Ongoing litigation may constrain EPAM's ability to pursue acquisitions, raise capital, or implement restructuring initiatives without triggering additional shareholder challenges.
Forward-Looking Considerations
The path forward for EPAM Systems likely involves several phases: investigation and evidence discovery, potential settlement negotiations, and either a court judgment or agreed resolution. The Pomerantz Law Firm's willingness to investigate suggests they believe there's sufficient potential merit in customer concentration disclosure failures to warrant pursuing the case.
Investors will be watching for:
- Management commentary in upcoming earnings calls about customer concentration and risk mitigation
- Legal reserve disclosures in quarterly SEC filings
- Customer concentration metrics in future 10-K filings
- Operational announcements regarding new customer wins and diversification efforts
EPAM Systems will need to demonstrate that the NEORIS customer decline was an isolated event and that the company maintains a stable, diversified customer base capable of supporting growth. Until such confidence is restored, and until the litigation risk is clarified, the stock will likely remain under pressure. The investigation underscores the critical importance of timely, comprehensive disclosure about material business developments—a lesson increasingly enforced by sophisticated securities litigation firms pursuing class action claims on behalf of institutional and retail investors.